Forbes Article: Healthcare Innovation Must Prioritize Patient Access

In a recent Forbes article, Surescripts CEO Frank Harvey asserts that patient access is paramount to realizing the true value of healthcare innovation. While acknowledging the potential of advancements like AI, Harvey emphasizes that their impact is constrained without addressing fundamental accessibility issues. A critical challenge highlighted is the affordability of prescription medications. Harvey notes that over half of U.S. adults express concerns about affording their prescriptions, leading to significant non-adherence. Approximately one in five adults do not fill prescriptions due to cost, and roughly one in seven ration their medication, ultimately worsening health outcomes. He posits that the most costly medication is the one a patient cannot afford. The article critiques the outdated processes hindering patient assistance programs. Relying on manual methods like phone calls and faxes for benefit verification causes substantial delays. These antiquated technologies, reminiscent of the 1990s, impede the effectiveness of even the most advanced AI systems, potentially leaving patients waiting weeks or months for essential medications. To address this, companies are adopting modern solutions, such as real-time digital benefit verification, to replace inefficient processes and expedite medication access. Furthermore, the article underscores the fragmentation within the healthcare system, referencing a recent report from the Office of the Assistant Secretary for Technology Policy. The report indicates a positive trend in patient engagement, with 65% of individuals nationwide accessing their health information digitally in 2024. Ultimately, Harvey advocates for a healthcare system that prioritizes both innovative breakthroughs and accessible solutions to optimize patient outcomes.